Bidi Vapor to appeal against the FDA’s MDO…

US – Federal: Just a week after the Food and Drug Administration (FDA) denied Bidi Vapor’s premarket tobacco product application (PMTA) for its “Classic” tobacco-flavoured e-cigarette, the company has announced that it will appeal the decision. On 26th January 2024, Bidi Vapor filed a petition requesting that the US Court of Appeals for the Eleventh Circuit review the marketing denial » Continue Reading.
I'm already a subscriber

Our Key Benefits

The global e-cigarette market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

ECigIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization